U.S. market Closed. Opens in 4 hours 14 minutes

AMRN | Amarin Corporation plc Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 10.13 - 10.43
52 Week Range 7.00 - 20.60
Beta 0.76
Implied Volatility 251.44%
IV Rank 6.45%
Day's Volume 61,638
Average Volume 89,700
Shares Outstanding 20,709,500
Market Cap 213,929,135
Sector Healthcare
Industry Biotechnology
IPO Date 1993-04-01
Valuation
Profitability
Growth
Health
P/E Ratio -2.58
Forward P/E Ratio N/A
EPS -4.00
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 275
Country Ireland
Website AMRN
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
AMRN's peers: SCLXW, BIIB, GILD, AZN, SNY, NVS, GSK, MRK, BMY, AMGN, ABBV, JNJ
*Chart delayed
Analyzing fundamentals for AMRN we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see AMRN Fundamentals page.

Watching at AMRN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on AMRN Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙